SEC Form 4 · accession 0001140361-15-033427
PLUS THERAPEUTICS, INC. · CNSY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Marc H Hedrick
Officer — President and CEO · Director
Period of report
Aug 24, 2015
Accepted (ET)
Aug 25, 2015 · 5:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001095981
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 21, 2015 | P | 5,000 | $0.35 | A | 33,600 | I | By Family Trust |
| Common Stock | holding | — | — | — | 504,611 | D | ||
| Common Stock | holding | — | — | — | 7,500 | I | By IRA |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These securities are owned by M Hedrick & T Hedrick TTEE Dr. Marc Hamilton Hedrick & TRA U/A DTD 09/13/1999.